6887 — Sunshine Lake Pharma Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$22.99bn
- HK$26.65bn
- CNY4.82bn
Annual cashflow statement for Sunshine Lake Pharma Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -1,480 | 1,385 | 141 | 440 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | 2,040 | 982 | 485 | 537 |
| Unusual Items | ||||
| Equity in Net Earnings/Losses | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 203 | -1,469 | -544 | -284 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Payable / Accrued Expenses | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 1,161 | 1,318 | 501 | 1,155 |
| Capital Expenditures | -1,017 | -535 | -1,225 | -927 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | -92.4 | -1,148 | 1,255 | 443 |
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -1,110 | -1,683 | 29.8 | -483 |
| Financing Cash Flow Items | -2,207 | 2,000 | -145 | -235 |
| Other Financing Cash Flow | ||||
| Total Cash Dividends Paid | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -314 | 1,314 | -971 | -666 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -261 | 949 | -439 | 5.99 |